The promises of immunotherapy in gliomas
- 1 December 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 30 (6) , 650-658
Abstract
Also owing to the limited efficacy of targeted therapies, there has been a renewed interest in targeting gliomas with immunotherapy. But despite considerable efforts using sophisticated approaches, proof of efficacy beyond case studies is still lacking. The purpose of this review is to summarize and discuss current immunotherapeutic approaches and efforts to understand mechanisms of response and resistance. The recent failure of large randomized clinical trials using targeted vaccines and checkpoint inhibitors to improve clinical outcome have underlined the grand challenges in this therapeutic arena and illustrated the necessity to understand the biology of immunotherapeutic interventions before conducting large randomized studies. However, these failures should not distract us from continuing to optimize immunotherapeutic concepts. The recent developments in transgenic T cell technologies and personalized vaccines but also rational combinatorial approaches offer tremendous opportunities and should be exploited carefully in early scientifically driven clinical trials. A profound understanding of the cellular and molecular mechanisms of response and resistance to immunotherapy to be gained from these thoroughly designed clinical trials will be essential to carve out successful strategies in selected patient populations.Keywords
This publication has 69 references indexed in Scilit:
- The Microenvironmental Landscape of Brain TumorsCancer Cell, 2017
- Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosisBrain, 2017
- Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant gliomaJournal of Neuroimmunology, 2013
- CSF-1R inhibition alters macrophage polarization and blocks glioma progressionNature Medicine, 2013
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with GlioblastomaPLOS ONE, 2012
- Prognostic significance and mechanism of Treg infiltration in human brain tumorsJournal of Neuroimmunology, 2010
- Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T CellsClinical Cancer Research, 2006
- Astrocyte–endothelial interactions at the blood–brain barrierNature Reviews Neuroscience, 2006
- Microglia in brain tumorsGlia, 2002
- Perivascular Microglial Cells of the CNS Are Bone Marrow-Derived and Present Antigen in VivoScience, 1988